Kaempferol sensitizes tumor necrosis factor-related apoptosis-inducing ligand-resistance chronic myelogenous leukemia cells to apoptosis.
Raedeh SaraeiHeshu Sulaiman RahmanMasoud SoleimaniMohammad Asghari JafarabadiAdel NaimiAli HassanzadehSaeed SolaliPublished in: Molecular biology reports (2021)
Consequently, it is reasonable to conclude that sensitization of chronic leukemia cells to TRAIL by kaempferol in vitro should be considered as a way of focusing clinical attention on leukemia therapy.